Lymphopenia and a low CD4 + cell count have been consistently reported as risk factors for PCP, and several studies have addressed the recommendation of PJP prophylaxis in non-HIV-infected patients based on total lymphocyte and/or CD4 + lymphocyte count. This evidence concerns the gene CD4 and pneumocystosis.